{"transactions":[{"id":671937,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-08-31T12:00:21.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":13.79,"value":27580.0,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person may be deemed a control person of this entity."}],"balance_after":11005,"source":{"system":"sec-edgar","filing":"0001493152-26-040736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000149315226040736/ownership.xml","form_type":"4"}},{"id":744505,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-06-09T21:30:02.000Z","date":"2026-06-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":11.79,"value":58950.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $11.735 to $11.883 per share. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":9005,"source":{"system":"sec-edgar","filing":"0001493152-26-027986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000149315226027986/ownership.xml","form_type":"4"}},{"id":822763,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-04-01T13:31:21.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":12.62,"value":63100.0,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price of shares purchased in a series of open market transactions on the transaction date at prices ranging from $12.5699 to $12.625 per share. The Reporting Persons undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reporting person may be deemed a control person of this entity."}],"balance_after":20001,"source":{"system":"sec-edgar","filing":"0001999371-26-007447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007447/ownership.xml","form_type":"4"}},{"id":834812,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2026-03-18T21:03:27.000Z","date":"2026-03-18","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":14.89,"value":223350.0,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person may be deemed a control person of this entity."}],"balance_after":15001,"source":{"system":"sec-edgar","filing":"0001999371-26-006235","document":"form4-lederman_031826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126006235/form4-lederman_031826.xml","form_type":"4"}},{"id":879446,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:01:33.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":134503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":134503,"derivative":{"exercise_price":17.8625,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":134503},"source":{"system":"sec-edgar","filing":"0001999371-26-004385","document":"lederman-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004385/lederman-form4_022626.xml","form_type":"4"}},{"id":879445,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:01:33.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":134504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":134504,"derivative":{"exercise_price":14.29,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":134504},"source":{"system":"sec-edgar","filing":"0001999371-26-004385","document":"lederman-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004385/lederman-form4_022626.xml","form_type":"4"}},{"id":1147252,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-05-15T21:08:40.000Z","date":"2025-05-15","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":21.55,"value":86200.0,"ownership":{"direct":true},"balance_after":4005,"source":{"system":"sec-edgar","filing":"0001999371-25-006261","document":"lederman-ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937125006261/lederman-ownership.xml","form_type":"4"}},{"id":1240530,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":123958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":123958,"derivative":{"exercise_price":10.0625,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":123958},"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1240529,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":123958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":123958,"derivative":{"exercise_price":8.05,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":123958},"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1240528,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":1,"price":0.15,"value":0.15,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Involuntary sale of fractional share following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1240527,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":0.22,"price":3.3,"value":0.726,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Involuntary sale of fractional share following a reverse stock split of the Issuer's common stock."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1240526,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-27T23:48:07.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":5.18,"price":3.38,"value":17.5084,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Involuntary sale of fractional share following a reverse stock split of the Issuer's common stock."}],"balance_after":5,"source":{"system":"sec-edgar","filing":"0001839882-25-011952","document":"lederman-form4_022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011952/lederman-form4_022725.xml","form_type":"4"}},{"id":1591446,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-03-06T22:01:16.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":1309911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The amendment corrects the Conversion or Exercise Price of from $0.0368 to $0.368."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":1309911,"derivative":{"exercise_price":0.368,"exercise_date":"2024-08-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":1309911},"source":{"system":"sec-edgar","filing":"0001999371-24-003168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124003168/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-29"}},{"id":1591445,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-03-06T22:01:16.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":1903680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":1903680,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":1903680},"source":{"system":"sec-edgar","filing":"0001999371-24-003168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124003168/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-29"}},{"id":1591444,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-03-06T22:01:16.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":235320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":235320,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":235320},"source":{"system":"sec-edgar","filing":"0001999371-24-003168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124003168/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-29"}},{"id":1609854,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:08:09.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":1309911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."}],"balance_after":1309911,"derivative":{"exercise_price":0.0368,"exercise_date":"2024-08-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":1309911},"source":{"system":"sec-edgar","filing":"0001999371-24-002952","document":"lederman-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002952/lederman-form4_022724.xml","form_type":"4"}},{"id":1609853,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:08:09.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":1903680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":1903680,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":1903680},"source":{"system":"sec-edgar","filing":"0001999371-24-002952","document":"lederman-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002952/lederman-form4_022724.xml","form_type":"4"}},{"id":1609852,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:08:09.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":235320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":235320,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":235320},"source":{"system":"sec-edgar","filing":"0001999371-24-002952","document":"lederman-form4_022724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002952/lederman-form4_022724.xml","form_type":"4"}},{"id":1992990,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:34:28.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":700000,"derivative":{"exercise_price":0.914,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001839882-23-004701","document":"lederman-form4_022322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223004701/lederman-form4_022322.xml","form_type":"4"}},{"id":1992989,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:34:28.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":700000,"derivative":{"exercise_price":0.731,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001839882-23-004701","document":"lederman-form4_022322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223004701/lederman-form4_022322.xml","form_type":"4"}},{"id":2217148,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2022-07-01T20:05:23.000Z","date":"2022-06-29","kind":"purchase","acquired":true,"shares":20000,"price":1.71,"value":34200.0,"ownership":{"direct":false,"nature":"By IRA Account"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares reported reflect a 1-for-32 reverse stock split effective May 17, 2022."}],"balance_after":24235,"source":{"system":"sec-edgar","filing":"0001387131-22-007441","document":"lederman-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122007441/lederman-form4.xml","form_type":"4"}},{"id":2316540,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2022-03-28T12:00:29.000Z","date":"2022-03-25","kind":"purchase","acquired":true,"shares":100000,"price":0.245,"value":24500.0,"ownership":{"direct":true},"balance_after":112177,"source":{"system":"sec-edgar","filing":"0001387131-22-003991","document":"lederman-form4_032522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122003991/lederman-form4_032522.xml","form_type":"4"}},{"id":2388188,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:17:16.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":5000000,"derivative":{"exercise_price":0.828,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001387131-22-002105","document":"lederman-form4_021522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002105/lederman-form4_021522.xml","form_type":"4"}},{"id":2388187,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:17:16.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":5000000,"derivative":{"exercise_price":0.621,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001387131-22-002105","document":"lederman-form4_021522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002105/lederman-form4_021522.xml","form_type":"4"}},{"id":2388186,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:17:16.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":5000000,"derivative":{"exercise_price":0.414,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001387131-22-002105","document":"lederman-form4_021522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002105/lederman-form4_021522.xml","form_type":"4"}},{"id":2388185,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:17:16.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":5000000,"derivative":{"exercise_price":0.207,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001387131-22-002105","document":"lederman-form4_021522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002105/lederman-form4_021522.xml","form_type":"4"}},{"id":2557635,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2021-09-28T21:04:03.000Z","date":"2021-09-28","kind":"purchase","acquired":true,"shares":12000,"price":0.61,"value":7320.0,"ownership":{"direct":true},"balance_after":12177,"source":{"system":"sec-edgar","filing":"0001387131-21-009696","document":"lederman-form4_092821.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713121009696/lederman-form4_092821.xml","form_type":"4"}},{"id":2771845,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2021-03-25T11:00:27.000Z","date":"2021-03-24","kind":"purchase","acquired":true,"shares":16733,"price":1.32,"value":22087.56,"ownership":{"direct":false,"nature":"By 401(k) plan"},"balance_after":135000,"source":{"system":"sec-edgar","filing":"0001387131-21-003875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713121003875/ownership.xml","form_type":"4"}},{"id":2832441,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2021-02-25T22:54:48.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":3000000,"derivative":{"exercise_price":1.53,"exercise_date":"2022-02-23","expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001387131-21-002890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713121002890/ownership.xml","form_type":"4"}},{"id":2832440,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2021-02-25T22:54:48.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":3000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":3000000,"derivative":{"exercise_price":1.22,"exercise_date":"2022-02-23","expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":3000000},"source":{"system":"sec-edgar","filing":"0001387131-21-002890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713121002890/ownership.xml","form_type":"4"}},{"id":2925423,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2021-01-04T22:01:25.000Z","date":"2020-12-30","kind":"purchase","acquired":true,"shares":35000,"price":0.68,"value":23800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.6801 to $0.6805, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":118267,"source":{"system":"sec-edgar","filing":"0001387131-21-000041","document":"lederman-form4_123020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713121000041/lederman-form4_123020.xml","form_type":"4"}},{"id":3055824,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2020-08-17T13:03:00.000Z","date":"2020-08-13","kind":"purchase","acquired":true,"shares":60000,"price":0.91,"value":54600.0,"ownership":{"direct":false,"nature":"By 401(k) plan"},"balance_after":83267,"source":{"system":"sec-edgar","filing":"0001387131-20-007592","document":"lederman-form4_0813020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120007592/lederman-form4_0813020.xml","form_type":"4"}},{"id":3159347,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2020-05-06T22:22:38.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"2. The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":2000000,"derivative":{"exercise_price":0.96,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001387131-20-004481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120004481/ownership.xml","form_type":"4"}},{"id":3159346,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2020-05-06T22:22:38.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"2. The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":2000000,"derivative":{"exercise_price":0.77,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001387131-20-004481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120004481/ownership.xml","form_type":"4"}},{"id":3243770,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2020-02-27T21:22:13.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":120000,"derivative":{"exercise_price":0.5,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001387131-20-002253","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120002253/ownership.xml","form_type":"4"}},{"id":3243769,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2020-02-27T21:22:13.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":120000,"derivative":{"exercise_price":0.4,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001387131-20-002253","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120002253/ownership.xml","form_type":"4"}},{"id":3352488,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2019-12-04T12:00:27.000Z","date":"2019-12-03","kind":"purchase","acquired":true,"shares":20000,"price":1.159,"value":23180.0,"ownership":{"direct":false,"nature":"By 401(k) plan"},"balance_after":23267,"source":{"system":"sec-edgar","filing":"0001387131-19-009327","document":"lederman-form4_120319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119009327/lederman-form4_120319.xml","form_type":"4"}},{"id":3535061,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2019-05-08T12:01:55.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":129757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":129757,"derivative":{"exercise_price":2.56,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":129757},"source":{"system":"sec-edgar","filing":"0001387131-19-003428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119003428/ownership.xml","form_type":"4"}},{"id":3535060,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2019-05-08T12:01:55.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":129758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":129758,"derivative":{"exercise_price":2.05,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":129758},"source":{"system":"sec-edgar","filing":"0001387131-19-003428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119003428/ownership.xml","form_type":"4"}},{"id":3571877,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2019-04-01T12:22:29.000Z","date":"2019-03-29","kind":"purchase","acquired":true,"shares":5000,"price":2.488,"value":12440.0,"ownership":{"direct":false,"nature":"By 401(k) Plan"},"balance_after":32670,"source":{"system":"sec-edgar","filing":"0001387131-19-002339","document":"lederman-form4_032919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119002339/lederman-form4_032919.xml","form_type":"4"}},{"id":3575156,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2019-03-28T21:13:49.000Z","date":"2019-03-26","kind":"purchase","acquired":true,"shares":25000,"price":2.375,"value":59375.0,"ownership":{"direct":false,"nature":"By 401(k) plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average purchase price. Actual purchase prices ranged from $2.335 to $2.40."}],"balance_after":27670,"source":{"system":"sec-edgar","filing":"0001387131-19-002230","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119002230/ownership.xml","form_type":"4"}},{"id":3628861,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2019-02-27T22:29:04.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":23265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":23265,"derivative":{"exercise_price":2.36,"exercise_date":"2020-02-26","expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":23265},"source":{"system":"sec-edgar","filing":"0001387131-19-001528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119001528/ownership.xml","form_type":"4"}},{"id":3628860,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2019-02-27T22:29:04.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":23265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":23265,"derivative":{"exercise_price":1.89,"exercise_date":"2020-02-26","expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":23265},"source":{"system":"sec-edgar","filing":"0001387131-19-001528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119001528/ownership.xml","form_type":"4"}},{"id":3878668,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-07-02T20:30:21.000Z","date":"2018-06-29","kind":"purchase","acquired":true,"shares":500,"price":4.64,"value":2320.0,"ownership":{"direct":true},"balance_after":17666,"source":{"system":"sec-edgar","filing":"0001615774-18-006088","document":"s111175_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418006088/s111175_form4.xml","form_type":"4"}},{"id":3880425,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-29T20:30:40.000Z","date":"2018-06-28","kind":"purchase","acquired":true,"shares":500,"price":4.58,"value":2290.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.57 to $4.59 per share, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp. (\"Tonix\"), any security holder of Tonix, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":17166,"source":{"system":"sec-edgar","filing":"0001615774-18-006006","document":"s111120_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418006006/s111120_form4.xml","form_type":"4"}},{"id":3881336,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-28T20:30:21.000Z","date":"2018-06-27","kind":"purchase","acquired":true,"shares":500,"price":4.55,"value":2275.0,"ownership":{"direct":true},"balance_after":16666,"source":{"system":"sec-edgar","filing":"0001615774-18-005896","document":"s111090_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418005896/s111090_form4.xml","form_type":"4"}},{"id":3893720,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-14T20:06:20.000Z","date":"2018-06-12","kind":"purchase","acquired":true,"shares":2000,"price":4.37,"value":8740.0,"ownership":{"direct":false,"nature":"By Lederman & Co., LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reporting person may be deemed to be a control person of this entity."}],"balance_after":20463,"source":{"system":"sec-edgar","filing":"0001615774-18-005290","document":"s110815_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418005290/s110815_form4.xml","form_type":"4"}},{"id":3893719,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-14T20:06:20.000Z","date":"2018-06-12","kind":"purchase","acquired":true,"shares":1000,"price":4.37,"value":4370.0,"ownership":{"direct":true},"balance_after":16166,"source":{"system":"sec-edgar","filing":"0001615774-18-005290","document":"s110815_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418005290/s110815_form4.xml","form_type":"4"}},{"id":3914021,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-05-30T20:05:18.000Z","date":"2018-05-25","kind":"purchase","acquired":true,"shares":4000,"price":3.17,"value":12680.0,"ownership":{"direct":false,"nature":"By 401(k) plan"},"balance_after":26700,"source":{"system":"sec-edgar","filing":"0001615774-18-004510","document":"s110480_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418004510/s110480_form4.xml","form_type":"4"}},{"id":4054659,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2018-02-15T21:08:53.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":156601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":156601,"derivative":{"exercise_price":4.25,"exercise_date":"2019-02-13","expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":156601},"source":{"system":"sec-edgar","filing":"0001615774-18-001263","document":"s109082_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001263/s109082_form4.xml","form_type":"4"}},{"id":4054658,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2018-02-15T21:08:53.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":156601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":156601,"derivative":{"exercise_price":3.4,"exercise_date":"2019-02-13","expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":156601},"source":{"system":"sec-edgar","filing":"0001615774-18-001263","document":"s109082_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001263/s109082_form4.xml","form_type":"4"}},{"id":4120876,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2017-12-27T19:04:32.000Z","date":"2017-12-26","kind":"purchase","acquired":true,"shares":5300,"price":3.61,"value":19133.0,"ownership":{"direct":false,"nature":"By 401(k) plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The volume weighted average purchase price of common stock purchased by the reporting person in open market transactions on the transaction date. The range of purchase prices on the transaction date was $3.5834 to $3.619 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":22700,"source":{"system":"sec-edgar","filing":"0001615774-17-007619","document":"s108549_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417007619/s108549_form4.xml","form_type":"4"}},{"id":4229451,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2017-08-18T19:40:47.000Z","date":"2017-08-17","kind":"purchase","acquired":true,"shares":15000,"price":3.0045,"value":45067.5,"ownership":{"direct":false,"nature":"By IRA account"},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001615774-17-004563","document":"s107264_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417004563/s107264_form4.xml","form_type":"4"}},{"id":4229450,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2017-08-18T19:40:47.000Z","date":"2017-08-16","kind":"purchase","acquired":true,"shares":5000,"price":2.99,"value":14950.0,"ownership":{"direct":false,"nature":"By IRA account"},"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001615774-17-004563","document":"s107264_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417004563/s107264_form4.xml","form_type":"4"}},{"id":4269181,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-30T21:38:43.000Z","date":"2017-06-30","kind":"purchase","acquired":true,"shares":5000,"price":4.328,"value":21640.0,"ownership":{"direct":false,"nature":"By IRA account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $4.32797964. The range of purchase prices on the transaction date was $4.3123 to $4.35 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001615774-17-003457","document":"s106735_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417003457/s106735_form4.xml","form_type":"4"}},{"id":4272514,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-26T21:29:16.000Z","date":"2017-06-26","kind":"purchase","acquired":true,"shares":5000,"price":4.3999,"value":21999.5,"ownership":{"direct":false,"nature":"By IRA account"},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001615774-17-003376","document":"s106692_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417003376/s106692_form4.xml","form_type":"4"}},{"id":4276107,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-20T20:30:21.000Z","date":"2017-06-20","kind":"purchase","acquired":true,"shares":20000,"price":4.22,"value":84400.0,"ownership":{"direct":false,"nature":"By IRA account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $4.220019425. The range of purchase prices on the transaction date was $4.13 to $4.25 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001615774-17-003262","document":"s106604_lederman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417003262/s106604_lederman.xml","form_type":"4"}},{"id":4413965,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2017-03-02T02:24:28.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2016 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 50% if the Issuer achieves enrollment of 250 patients in its HONOR study by December 31, 2017, with the remaining 50% vesting 1% for each patient that is enrolled in the HONOR study by December 31, 2017 in excess of 250, subject to a one year minimum service period prior to vesting."}],"balance_after":160000,"derivative":{"exercise_price":0.55,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001615774-17-000860","document":"s105459_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417000860/s105459_form4.xml","form_type":"4"}},{"id":4413964,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2017-03-02T02:24:28.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2016 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":160000,"derivative":{"exercise_price":0.55,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001615774-17-000860","document":"s105459_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417000860/s105459_form4.xml","form_type":"4"}},{"id":4453798,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-13T11:06:20.000Z","date":"2016-06-30","kind":"other","acquired":true,"shares":3296,"price":1.74,"value":5735.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. Employee Stock Purchase Plan."}],"balance_after":79111,"source":{"system":"sec-edgar","filing":"0001615774-17-000513","document":"s105310_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577417000513/s105310_form5.xml","form_type":"5"}},{"id":4544887,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2016-11-22T21:23:31.000Z","date":"2016-11-21","kind":"purchase","acquired":true,"shares":98000,"price":0.4278,"value":41924.4,"ownership":{"direct":false,"nature":"By 401(k) plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.427821. The range of purchase prices on the transaction date was $0.4191 to $0.4299 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price."}],"balance_after":133000,"source":{"system":"sec-edgar","filing":"0001615774-16-008539","document":"s104774_lederman.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577416008539/s104774_lederman.xml","form_type":"4"}},{"id":4571817,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Purchase Warrant","published_at":"2016-10-31T20:37:07.000Z","date":"2016-10-31","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Included in the purchase of 10,000 Units at a price of $0.55 per Unit. Each Unit consisted of one share of common stock and one warrant exercisable immediately for one-half (0.50) share of common stock at an exercise price of $0.63 per share."}],"balance_after":10000,"derivative":{"exercise_price":0.63,"exercise_date":"2016-10-31","expiration_date":"2021-10-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001615774-16-007912","document":"s104485_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577416007912/s104485_form4.xml","form_type":"4"}},{"id":4571816,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":18368,"kind":"person","name":"LEDERMAN SETH","position":1,"cik":"0001563420","reported_name":"LEDERMAN SETH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2016-10-31T20:37:07.000Z","date":"2016-10-31","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Included in the purchase of 10,000 Units at a price of $0.55 per Unit. Each Unit consisted of one share of common stock and one warrant exercisable immediately for one-half (0.50) share of common stock at an exercise price of $0.63 per share."}],"balance_after":90815,"source":{"system":"sec-edgar","filing":"0001615774-16-007912","document":"s104485_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577416007912/s104485_form4.xml","form_type":"4"}}]}